Immunovant is a company that creates monoclonal antibodies to treat autoimmune diseases. Their product batoclimab is a fully human monoclonal antibody that is being tested in clinical trials for multiple autoimmune diseases. They were established in 2018 and are based in New York, and are owned by Roivant Sciences Ltd.